tradingkey.logo
tradingkey.logo
Suchen

Stereotaxis Inc

STXS
Zur Watchlist hinzufügen
1.790USD
+0.020+1.13%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
174.50MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Stereotaxis Inc Unternehmen

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc Informationen

BörsenkürzelSTXS
Name des UnternehmensStereotaxis Inc
IPO-datumAug 12, 2004
CEOFischel (David Leo)
Anzahl der mitarbeiter139
WertpapierartOrdinary Share
GeschäftsjahresendeAug 12
Addresse710 N Tucker Blvd
StadtST. LOUIS
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl63101
Telefon13146786100
Websitehttps://www.stereotaxis.com/
BörsenkürzelSTXS
IPO-datumAug 12, 2004
CEOFischel (David Leo)

Führungskräfte von Stereotaxis Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Stereotaxis Inc?

Die fünf größten Anteilseigner von Stereotaxis Inc sind: Mr. David W. Benfer

Wie viele Institutionen halten Anteile an Stereotaxis Inc (STXS)?

Mit Stand vom 2026Q1 halten 205 Institutionen Anteile an Stereotaxis Inc, mit einem Gesamtmarktwert von etwa 49.70M, was 50.99% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 2238158.00 gestiegen.